SPOTLIGHT -
The immune-brain loop: a world where more and more clinicians boldly go-and thrive-among new discoveries.
New Phase 3 Study Results on Lumateperone, An Adjunctive Therapy to Antidepressants
Blue Light Blockers: A Behavior Therapy for Mania
The Week in Review: April 1-5
Blue Light, Depression, and Bipolar Disorder
ALTO-203 for Major Depressive Disorder and Anhedonia: Phase 2 Study Initiated
Rejoyn Becomes First Prescription Digital Therapeutic Authorized for Treatment of MDD